Delivery Order SPE2DB20D2014-SPE2DB25FC48E
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.16 firm fixed-price delivery order is for the supply of 4,562,816,061 units of Telmisartan 40 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,468.08 firm fixed-price delivery order is for the supply of Telmisartan 40 mg tablets. The contract has an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,140.36, is for the delivery of Telmisartan 40 mg tablets in 30-count packages. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Telmisartan 40 mg tablets in 30-count packages, with a ceiling value of $2,287.16 and a period of performance through June 12, 2025. This contract is not designated as a set-aside and is an open competition. Amerisourcebergen Drug...
- This federal contract award, valued at $2,589.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 40 mg tablets, a cardiovascular medication, to support military and government healthcare programs. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company and subsidiary of Cencora, Inc. The contract, valued at $2,239.90, is for the delivery of Telmisartan 40 mg tablets to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,113.97 delivery order is for the supply of 4559421846 - Telmisartan 40 mg Tablets, a cardiovascular medication. The award is not designated under any set-aside program, indicating open competition. It is a firm fixed-price contract with a completion date of December 20, 2022. Amerisourcebergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $9,373.64 firm fixed-price delivery order is for the supply of telmisartan 40 mg tablets, a medication used to treat high blood pressure. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,185.08 firm fixed-price delivery order is for the supply of Telmisartan 40 mg tablets, a medication used to treat high blood pressure. The award is not set aside and appears to be part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Telmisartan 40 mg tablets. The award, valued at $1,293.60, is a Firm Fixed Price delivery order contract that will run through February 4, 2025. This contract appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC48EDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $3,094.32 firm fixed price delivery order is for the supply of Telmisartan 40 mg tablets. The award is not set aside and is part of Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This comprehensive global pharmaceutical support vehicle enables Amerisourcebergen to supply a vast range of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to support military and government healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/16/25 |